TP53 and B-cell non-Hodgkin lymphoma: Mutational status of tumor suppressor gene p53 is variable within our panel of B cell lymphoma cell lines (Table 1), however p53 status is not a distinctive marker for treatment efficacy (Supplementary Fig. 3F).